Genpharmasec Ltd
BSE: 531592
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 51.66+43.5% | 36.01+14.1% | 31.56+160.6% | 12.11-10.6% | 13.56+62.6% | 8.34+44.5% | 5.77 |
| Other Income | 1.62+13.2% | 1.43+42.9% | 1.00+21.6% | 0.82-22.5% | 1.06+13.9% | 0.93+8.5% | 0.86 |
| Total Income | 53.28+42.3% | 37.44+15.0% | 32.56+151.7% | 12.94-11.5% | 14.62+57.7% | 9.27+39.8% | 6.63 |
| EXPENSES | |||||||
| Expenditure | 50.42+36.5% | 36.95+18.5% | 31.18+177.7% | 11.23-23.4% | 14.65+94.6% | 7.53+34.6% | 5.60 |
| Tax | 0.54+302.8% | -0.27-147.6% | 0.56+285.2% | 0.15-23.4% | 0.19-68.6% | 0.61+1691.2% | 0.03 |
| PROFIT | |||||||
| PBT | 2.86+487.2% | 0.49-64.7% | 1.38-19.1% | 1.71+4918.9% | -0.04-102.0% | 1.74+68.5% | 1.03 |
| Net Profit | 2.32+206.6% | 0.76-7.3% | 0.82-47.7% | 1.56+787.5% | -0.23-120.1% | 1.13+13.0% | 1.00 |
| KEY METRICS | |||||||
| OPM % | 3.07%+4.95pp | -1.88%-3.48pp | 1.60%-6.68pp | 8.28%+15.63pp | -7.35%-15.20pp | 7.85%+6.31pp | 1.54% |
| NPM % | 4.35%+2.33pp | 2.02%-0.49pp | 2.51%-9.54pp | 12.05%+13.60pp | -1.55%-13.72pp | 12.17%-2.89pp | 15.06% |
| EPS | 0.04+300.0% | 0.01+0.0% | 0.01-66.7% | 0.03+200.0% | 0.01-50.0% | 0.02+0.0% | 0.02 |
Corporate Events
Board MeetingGENPHARMA
20252Sep
Board Meeting
Fix the Day, Date, Time and Mode of Annual General Meeting, …
BSE Filing ↗ Board MeetingGENPHARMA
202427Jun
Board Meeting
To Fix the Day, Date, Time and Mode of Annual General Meetin…
BSE Filing ↗ Board MeetingGENPHARMA
202424May
Board Meeting
Consider and approve:</br>1. The Audited Standalone & Consol…
BSE Filing ↗